{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/fungal-nail-infection/diagnosis/differential-diagnosis/","result":{"pageContext":{"chapter":{"id":"d84aa70d-b236-5783-9eeb-e1181b1311f8","slug":"differential-diagnosis","fullItemName":"Differential diagnosis","depth":2,"htmlHeader":"<!-- begin field 19594af1-a4e9-4235-9c46-ae3629193895 --><h2>What else might it be?</h2><!-- end field 19594af1-a4e9-4235-9c46-ae3629193895 -->","summary":"","htmlStringContent":"<!-- begin item b9c1f607-6a65-4f53-bae1-3425289e7f02 --><!-- begin field c8964134-b85f-4242-89c8-e585373e2255 --><p><strong>Nail conditions that may present similarly to (and may co-exist with) fungal nail infection include:</strong></p><ul><li>Psoriasis — there may be nail pitting, subungual hyperkeratosis, nail dystrophy, and the 'oil drop sign'. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/psoriasis/\">Psoriasis</a> for more information.</li><li>Lichen planus — this condition may affect the skin, mucous membranes, and/or nails.<ul><li>Nails may be thinned (or may thicken) and become grooved, fissured, and ridged; they may be discoloured and separate from the nail bed. The cuticle may be destroyed leaving a scar at the proximal aspect of the nail. The nails may shed, stop growing, or completely disappear (rare).</li><li>Skin lesions are typically purplish, shiny, flat-topped, firm papules varying from pin-point to larger than a centimetre in diameter; lesions are often crossed by fine white lines (Wickham's striae).</li></ul></li><li>Eczema — affected nails are irregular, ridged (corrugated surface), and thickened. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/eczema-atopic/\">Eczema - atopic</a> and <a class=\"topic-reference external-reference\" href=\"/topics/seborrhoeic-dermatitis/\">Seborrhoeic dermatitis</a> for more information.</li><li>Alopecia areata — nail changes include nail pitting, ridging, and brittle nails. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/alopecia-areata/\">Alopecia areata</a> for more information.</li><li>Bacterial infection — nails may turn black or green, especially if infected with <em>Pseudomonas aeruginosa</em>. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/paronychia-acute/\">Paronychia - acute</a> for more information.</li><li>Viral warts — periungual warts grow at the sides or under the nails and can distort nail growth; may be longitudinal depressed grooves in the nail plate. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/warts-verrucae/\">Warts and verrucae</a> for more information.</li><li>Onychogryphosis — the nail is thickened with scaling under the nail; it is more common in older people.</li><li>Trauma — the nail plate may look abnormal but the nail bed should be normal. There may be distal onycholysis (nail separates from the nail bed) with repeated trauma. It may cause white spots which can mimic proximal onychomycosis.</li><li>Yellow nail syndrome — the nail plate is discoloured green-yellow; nails are hard with elevated longitudinal curvature. The nails may shed. Associated with bronchiectasis, lymphoedema, and chronic sinusitis.</li><li>Periungual squamous cell carcinoma or Bowen's disease — single nail affected typically; warty changes of the nail fold; oozing or bleeding from the edge of the nail may be seen. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/skin-cancers-recognition-referral/\">Skin cancers - recognition and referral</a> for more information.</li><li>Subungual malignant melanoma — abnormal black pigmentation of the nail plate or nail bed which extends onto the nail fold; typically slowly increases in size becoming increasingly irregular in colour and border. There may be eventual bleeding and ulceration. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/melanoma-pigmented-lesions/\">Melanoma and pigmented lesions</a> for more information.</li></ul><!-- end field c8964134-b85f-4242-89c8-e585373e2255 --><!-- end item b9c1f607-6a65-4f53-bae1-3425289e7f02 -->","topic":{"id":"1303927b-7e0c-517d-85e9-841c9ac02151","topicId":"d2c6135f-fef1-4a56-80dc-161c93380c7d","topicName":"Fungal nail infection","slug":"fungal-nail-infection","lastRevised":"Last revised in March 2018","chapters":[{"id":"bc563964-f1b0-559d-9f21-380162710ddf","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"dd347390-fb63-5e80-9fab-bd3cc4704341","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"0cdd100c-c9d0-5685-980c-52f246d1100e","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"886d32db-68df-5055-b459-55404c1f011e","slug":"changes","fullItemName":"Changes"},{"id":"c1cacd2b-dba0-5341-a274-66fd882b2036","slug":"update","fullItemName":"Update"}]},{"id":"9f0a65a3-9309-5a00-a9fa-bda2fb7a49c4","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"1121797b-5555-5e24-a9ae-aabc657725dd","slug":"goals","fullItemName":"Goals"},{"id":"aa660497-e222-5e9d-b282-3069500c380f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"49df22af-d1aa-56cd-b2dc-30e6ecc84ca8","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"a79a5fd4-4f6a-5d37-8714-e4bd3bea76b0","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"6db25a8b-db82-5b72-bade-fa216c349fd8","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"2515b15e-47ac-5e93-acaf-588daa2e06f0","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d257da5b-218f-50fc-96b1-55ec4b44f5cd","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"7ccd879d-9979-5f0b-b655-8da37ca04149","slug":"definition","fullItemName":"Definition"},{"id":"20d20421-b2ba-513f-87b5-3fad4f731aa5","slug":"causes","fullItemName":"Causes"},{"id":"3142330a-0287-5835-8a69-857972828fb2","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"29b083db-9488-5407-92df-43f4952d8df3","slug":"prevalence","fullItemName":"Prevalence"},{"id":"d7dd4e0b-6a97-5db7-bfa3-aa690c7974af","slug":"complications","fullItemName":"Complications"},{"id":"3a29be3f-ea9f-56a3-b8d7-78341665856e","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"4346dd42-e5eb-550e-a004-7c8e7103a196","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"b6a7486c-a6d8-5d8b-918c-8610bf76e212","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"eec0a81e-c0c0-5f9d-951e-f19c41cfafaf","slug":"assessment","fullItemName":"Assessment"},{"id":"d84aa70d-b236-5783-9eeb-e1181b1311f8","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"12363e3a-9d3f-54c7-8f68-1145b8f312b3","fullItemName":"Management","slug":"management","subChapters":[{"id":"36068044-ec28-5f59-b737-dd89aa53cca5","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"94da5137-b65a-5fa1-a933-bbcaa1a5c10b","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"6780cd52-ecfd-5eba-8c7e-66bc71b64ed2","slug":"topical-amorolfine","fullItemName":"Topical amorolfine"},{"id":"7009ace0-8da0-5da4-917e-8900ae3cc390","slug":"oral-terbinafine","fullItemName":"Oral terbinafine"},{"id":"5d413d25-a998-5ee4-ad9d-be6306400282","slug":"oral-itraconazole","fullItemName":"Oral itraconazole"}]},{"id":"0b102b3a-ebce-5c6e-9670-3610defc871d","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"bc0bd4bc-1b10-52dc-b942-cd4682774d01","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"dc202e28-37b1-5789-a14a-b5a0850d8cf8","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"49993e8c-ae7a-5891-bf43-21a6406ce1b5","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b6aa45b7-d833-599f-8bcc-4d08c6c264bb","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"2805cbb7-09b5-5875-a0c1-c501223c6ab3","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"595745a2-d654-5e3b-850e-eac6532bd5db","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"74af204e-7571-5d05-963f-0c0614335fbf","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"4346dd42-e5eb-550e-a004-7c8e7103a196","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"dd2607f4-e3ef-5b6b-8e43-f3d863a19a74","slug":"basis-for-recommendation-d90","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 18d752ea-d4c2-41c3-8d73-a73d00b98d75 --><h3>Basis for recommendation</h3><!-- end field 18d752ea-d4c2-41c3-8d73-a73d00b98d75 -->","summary":null,"htmlStringContent":"<!-- begin item d908b6ed-00e5-44b8-b129-a73d00b98d87 --><!-- begin field e72fa169-61a4-4b47-9f9e-a73d00b98d75 --><p>The information on the differential diagnosis of fungal nail infection is based on the National Institute for Health and Care Excellence (NICE) clinical guideline <em>Suspected cancer: recognition and referral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">NICE, 2017</a>], expert opinion in the British Association of Dermatologists' <em>Guidelines for the management of onychomycosis 2014</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">Ameen, 2014</a>], and expert opinion in review articles on fungal nail infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">Lynde, 2001</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">Westerberg, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/fungal-nail-infection/references/\">Eisman, 2014</a>].</p><!-- end field e72fa169-61a4-4b47-9f9e-a73d00b98d75 --><!-- end item d908b6ed-00e5-44b8-b129-a73d00b98d87 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}